Sam Eiber
Stock Analyst at BTIG
(2.77)
# 2,810
Out of 5,065 analysts
71
Total ratings
44.4%
Success rate
3.5%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintained: Buy | $20 | $14.41 | +38.79% | 3 | Oct 20, 2026 | |
| EOLS Evolus | Reiterated: Buy | $13 | $8.57 | +51.69% | 14 | Oct 15, 2026 | |
| INMD InMode | Maintained: Hold | n/a | $14.79 | - | 11 | Oct 14, 2026 | |
| AIRS AirSculpt Technologies | Maintained: Hold | n/a | $2.61 | - | 6 | Oct 12, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $103 | $74.51 | +38.24% | 15 | Oct 6, 2026 | |
| STIM Neuronetics | Reiterated: Buy | $5 → $6 | $3.04 | +97.37% | 2 | Sep 18, 2026 | |
| SBC SBC Medical Group Holdings | Reiterated: Buy | $8 | $4.34 | +84.54% | 3 | Aug 13, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $105 | $87.19 | +20.43% | 7 | Aug 11, 2026 | |
| APYX Apyx Medical | Reiterated: Buy | $6 | $3.05 | +96.72% | 8 | Aug 7, 2026 | |
| ICUI ICU Medical | Rated: Buy | $170 → $200 | $161.00 | +24.22% | 2 | Aug 7, 2026 |
BrainsWay
Oct 20, 2026
Maintained: Buy
Price Target: $20
Current: $14.41
Upside: +38.79%
Evolus
Oct 15, 2026
Reiterated: Buy
Price Target: $13
Current: $8.57
Upside: +51.69%
InMode
Oct 14, 2026
Maintained: Hold
Price Target: n/a
Current: $14.79
Upside: -
AirSculpt Technologies
Oct 12, 2026
Maintained: Hold
Price Target: n/a
Current: $2.61
Upside: -
Establishment Labs Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $103
Current: $74.51
Upside: +38.24%
Neuronetics
Sep 18, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $3.04
Upside: +97.37%
SBC Medical Group Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $4.34
Upside: +84.54%
Merit Medical Systems
Aug 11, 2026
Reiterated: Buy
Price Target: $105
Current: $87.19
Upside: +20.43%
Apyx Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $3.05
Upside: +96.72%
ICU Medical
Aug 7, 2026
Rated: Buy
Price Target: $170 → $200
Current: $161.00
Upside: +24.22%